Understanding Cancer

Understanding Cancer

Where Quality of Life Intersects With Making Medical Decisions

Gareth Morgan, MD, PhD, FRCP, FRCPath, Robyn M. Scherber, MD, MPH, Ruben Mesa, MD, Andrew Schorr, Esther Schorr

Patient Stories

Genetic Testing From a Myeloma Patient Perspective

George Burrell, Peg Burrell, Doug Kenaley, Peggy Lindley, Nancy Raimondi, Jack Aiello

Understanding Cancer

My Blood Test Showed My Lymphs As High, Should I Be Concerned?

Susan J. Leclair, PhD, CLS (NCA)

Understanding Cancer

Will CAR T-Cell Therapy Work for Solid Tumor Cancers?

Andrew Schorr, David Maloney, MD, PhD

Understanding Cancer

Patient Advocate Shares What's Ahead in Stem Cell Research and Treatments

Robert "Bob" Klein, Andrew Schorr

What Is CLL?

Understanding Your CLL Diagnosis: What Tests Are Recommended to Figure Out Your Genetic Subtype?

Philip Thompson, MB, BS, Andrew Schorr

Understanding Cancer

What Is Minimal Residual Disease (MRD)?

Understanding Cancer

Blood Tests 101: Understanding the Acronyms

Susan J. Leclair, PhD, CLS (NCA)

Understanding Cancer

Which Types of Cancer Patients Can Benefit From CAR T-Cell Therapy?

Jon Arnason, MD, Esther Schorr

Understanding Cancer

How Are Lab Test Reference Ranges Determined?

William Wierda, MD, PhD, Susan Leclair, PhD, CLS (NCA), Andrew Schorr

Understanding Cancer

Are There Specific Blood Tests Used in Clinical Trials?

Susan J. Leclair, PhD, CLS (NCA)

Understanding Cancer

Can Blood Tests Be Negotiated by Professional Lab Organizations?

Susan J. Leclair, PhD, CLS (NCA)

Find a clinical trial

Learn More